Table 1: Recommendations for Screening Clinical Breast Exam (CBE) and Mammograms (MGM)

Table 1:
Recommendations for Screening Clinical Breast Exam (CBE) and Mammograms (MGM)
American Cancer Society (ACS)	US Preventive Services Task Force (USPSTF)	National Cancer Institute (NCI/NIH)	Canadian Task Force on Preventive Health Care (CTF)	American College of Radiology
Age 20-39
CBE every 3 years		No data for benefit, nor for performing "baseline MGM"
Age 40-49
CBE and MGM yearly	MGM with or without CBE every 1-2 years	Data from screening trials presented, include number needed to screen, discuss screening with patient	Recommended against screening	MGM and CBE yearly
Age 50-69
CBE and MGM yearly	MGM with or without CBE every 1-2 years	MGM with or without CBE reduces mortality	CBE and MGM during periodic health examination	MGM and CBE yearly
Age 70+
Cessation of screening is not age related but due to comorbidity	When to discontinue MGM is unclear; those with comorbid conditions less likely to benefit	Screening may or may not be helpful